Close Menu

NEW YORK (GenomeWeb) — Centogene said today that it has launched a two-year study to investigate the genetic factors involved in Parkinson's disease in collaboration with the University of Lübeck in Germany.

The study — called the Rostock International Parkinson's Disease Study, or ROPAD — will enroll around 10,000 individuals worldwide and use Centogene's CentoCard dried blood spot collection kit to identify study participants with mutations in Parkinson's disease-associated genes including LRRK2 and GBA.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.